IXHL NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Incannex Healthcare Ltd ADR · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 3.15 USD
7.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -32.7% below the Trend Line and sits at 2.6% of its 52-week range. The latest completed week returned 7.3%, after a -6.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 45/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 53d.

Setup score 18 out of 100
Latest Close 3.15 USD 7 Aug 2026
1W Return 7.3% latest completed week
4W Return -6.9% short-term follow-through
12W Return -20.3% quarterly tape
Trend Breadth 5.8% 3 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 38.59% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.3% Latest completed week; four-week move -6.9%. Indicator stack 3/47 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.59% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 45/100 conviction; expected move 82.7%. News sentiment 51/100 67 relevant articles in the latest sentiment read. Event risk 53d Next report is scheduled for 05 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -32.7% below the Trend Line and sits at 2.6% of its 52-week range. The latest completed week returned 7.3%, after a -6.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1612-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.9% over four weeks, -20.3% over 12 weeks, and -76.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W7.3%
4W-6.9%
12W-20.3%
26W-63.5%
52W-76.2%
Active trend streak0 weeks
Active weeks in one year3
Trend breadth5.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.15Latest activity-pressure read.
Pressure change-76.5%Four-week change in activity pressure.
Leadership-67.64Latest relative-leadership reading.
RS change3.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 77%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value54/100Relative valuation strength. Underlying universe rank 47; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth54/100Revenue and earnings growth. Underlying universe rank 47; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
566.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-67.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-240.2%
Gross profit retained from each unit of revenue.
Operating margin
-84164.7%
Operating profit retained from revenue.
Free-cash-flow margin
-37975.9%
Free cash flow generated from revenue.
Return on invested capital
-4682.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-52.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

IXHL shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 0.28, expected move of 82.7%, and Sharemaestro trend signal inactive.

Conviction45/100
Expected move82.7%
Put/call volume0.28
Pressure66
Speculation36
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 67 relevant articles.

14 positive · 40 neutral · 13 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings53dNext report is scheduled for 05 Oct 2026; event risk rises as the date approaches.
Options expected move82.7%Nearest-chain priced movement where available.
52-week drawdown-88.6%Distance below the 52-week high.
13-week volatility12.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+31.2%Week of 12 Jun.
Worst week-49.5%Week of 27 Feb.
Latest week+7.3%Week of 7 Aug.

Shape of recent returns

Strong gains9
Modest gains1
Flat weeks0
Modest losses2
Sharp losses14
Recent vol12.7%13-week weekly-return volatility.
Base vol15.3%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew12.2% / -10.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape18/100

Trend, activity pressure, participation, and risk combine to a 18/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.16; No reversal markers Next-Week ExpectancyNegative 38.59%

Next-week expectancy is negative with a 38.59% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 48 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options33/100

IXHL shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 0.28, expected move of 82.7%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 82.7% Sentiment51/100

Weighted news tone is neutral across 67 relevant articles.

Incannex Healthcare Inc (IXHL) Institutional Confidence Insiders50/100

No recent insider transaction evidence is stored.

 Earnings53d

Next report is scheduled for 05 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263.15 USD7.3%4.69 USD43.36 USD0.15-67.64524.8KOff
31 Jul 20262.94 USD-0.3%4.98 USD43.64 USD0.26-69.14397.5KOff
24 Jul 20262.95 USD-6.9%5.27 USD43.94 USD0.46-69.57473.5KOff
17 Jul 20263.17 USD-6.5%5.57 USD44.23 USD0.58-69.93852.1KOff
10 Jul 20263.39 USD-14.6%5.90 USD44.53 USD0.63-70.241.5MOff
3 Jul 20263.97 USD16.1%6.21 USD44.84 USD0.65-64.831.3MOff
26 Jun 20263.42 USD-3.9%6.54 USD45.14 USD0.59-69.661.4MOff
19 Jun 20263.56 USD-7.0%6.78 USD45.45 USD0.48-70.061.1MOff
12 Jun 20263.83 USD31.2%6.98 USD45.76 USD0.37-67.232.6MOff
5 Jun 20262.92 USD-12.8%7.20 USD46.08 USD0.22-74.641.0MOff
29 May 20263.35 USD-4.8%7.45 USD46.41 USD0.10-72.41957.0KOff
22 May 20263.52 USD-11.1%7.72 USD46.74 USD-0.02-70.43810.0KOff
15 May 20263.96 USD-13.5%7.95 USD47.08 USD-0.24-66.641.6MOff
8 May 20264.58 USD0.7%8.17 USD47.41 USD-0.51-61.961.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context